Your browser doesn't support javascript.
loading
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
Innis, Bruce L; Scorza, Francesco Berlanda; Blum, Jeremy S; Jain, Varsha K; Aguilar, Anastazia Older; Post, Diane J; Roberts, Paul C; Wairagkar, Niteen; White, Janet; Bresee, Joseph.
Afiliación
  • Innis BL; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001, USA. Electronic address: binnis@path.org.
  • Scorza FB; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001, USA. Electronic address: fberlanda-scorza@path.org.
  • Blum JS; Bill & Melinda Gates Foundation, PO Box 23350, Seattle, WA 98102, USA. Electronic address: Jeremy.Blum@gatesfoundation.org.
  • Jain VK; Bill & Melinda Gates Foundation, PO Box 23350, Seattle, WA 98102, USA.
  • Aguilar AO; Bill & Melinda Gates Foundation, PO Box 23350, Seattle, WA 98102, USA. Electronic address: Anastazia.OlderAguilar@gatesfoundation.org.
  • Post DJ; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-9826, USA. Electronic address: postd@niaid.nih.gov.
  • Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-9826, USA. Electronic address: paul.roberts@nih.gov.
  • Wairagkar N; Bill & Melinda Gates Foundation, PO Box 23350, Seattle, WA 98102, USA.
  • White J; Bill & Melinda Gates Foundation, PO Box 23350, Seattle, WA 98102, USA. Electronic address: Janet.White@gatesfoundation.org.
  • Bresee J; Influenza Division, Centers for Disease Control and Prevention, and Task Force for Global Health, Atlanta, USA. Electronic address: jbresee@taskforce.org.
Vaccine ; 37(35): 4830-4834, 2019 08 14.
Article en En | MEDLINE | ID: mdl-31362820
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Vacunas contra la Influenza / Vacunación / Congresos como Asunto / Gripe Humana Tipo de estudio: Guideline / Prognostic_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Vacunas contra la Influenza / Vacunación / Congresos como Asunto / Gripe Humana Tipo de estudio: Guideline / Prognostic_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article